The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing ...
Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...
The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...
The company doesn't seem like it will generate pops in key fundamentals anytime soon.
According to Nova One Advisor, the global immunoassays market size is calculated at USD 28.51 billion in 2025 and is expected ...
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...
GROVE CITY, Ohio, Oct. 30, 2025 /PRNewswire/ -- Tosoh Bioscience, Inc., a market leader in clinical diagnostics has received U.S. FDA 510 (k) clearance for its next-generation Tosoh Automated ...
The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.
The Model 422 electro-eluter is an electroelution cell for preparative recovery of biomolecules from agarose and acrylamide gels. The eluter combines with the tank and lid of the Mini Trans-Blot® cell ...
The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...
Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.
Bioinspired materials are synthetic materials whose structure, properties or function mimic those of natural materials or living matter. Examples of bioinspired materials are light-harvesting photonic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results